SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 474.34 |
| Enterprise Value ($M) | 395.36 |
| Book Value ($M) | 172.94 |
| Book Value / Share | 2.44 |
| Price / Book | 2.74 |
| NCAV ($M) | 172.09 |
| NCAV / Share | 2.43 |
| Price / NCAV | 2.76 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.51 |
| Return on Equity (ROE) | -0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 16.55 |
| Current Ratio | 16.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 187.51 |
| Assets | 188.36 |
| Liabilities | 15.42 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.43 |
| Operating Income | -83.51 |
| Net Income | -88.45 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -75.81 |
| Cash from Investing | 13.73 |
| Cash from Financing | 86.11 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | State Street Corp | 5.51 | -54.80 | |
| 13G | Millennium Management Llc | 5.40 | ||
| 13G/A | Nuveen Asset Management, LLC | 2.88 | ||
| 13G/A | Teachers Advisors, Llc | 2.88 | ||
| 13G/A | Tiaa Cref Investment Management Llc | 2.88 | -47.11 | |
| 13G | Ameriprise Financial Inc | 7.79 | ||
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Tang Capital Partners Lp | 5.10 | 1.83 | |
| 13G/A | Vanguard Group Inc | 6.65 | 41.05 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -99.99 | |
| 13G | BlackRock Inc. | 7.50 | 320.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 392,210 | 1,948,907 | 20.12 | |
| 640,227 | 3,072,075 | 20.84 | |
| 483,051 | 1,679,367 | 28.76 | |
| 388,330 | 1,775,478 | 21.87 | |
| 615,255 | 2,059,877 | 29.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADMA – ADMA Biologics, Inc. | AFMD – Affimed N.V. |
| ALIM – Alimera Sciences, Inc. | ANIP – ANI Pharmaceuticals, Inc. |
| APGE – Apogee Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io